165 related articles for article (PubMed ID: 28218902)
1. Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway.
Wu MJ; Kim MR; Chen YS; Yang JY; Chang CJ
Oncogene; 2017 Jun; 36(22):3193-3206. PubMed ID: 28218902
[TBL] [Abstract][Full Text] [Related]
2. TET2 directs mammary luminal cell differentiation and endocrine response.
Kim MR; Wu MJ; Zhang Y; Yang JY; Chang CJ
Nat Commun; 2020 Sep; 11(1):4642. PubMed ID: 32934200
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase C Alpha (PKCα) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (RARβ) activation in mammary cancer cells.
Bessone MID; Berardi DE; Cirigliano SM; Delbart DI; Peters MG; Todaro LB; Urtreger AJ
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3241-3253. PubMed ID: 32865619
[TBL] [Abstract][Full Text] [Related]
4. Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells.
Shang Y; Baumrucker CR; Green MH
J Biol Chem; 1999 Jun; 274(25):18005-10. PubMed ID: 10364250
[TBL] [Abstract][Full Text] [Related]
5. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
6. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
7. [All-trans retinoic acid effectively inhibits breast cancer stem cells growth in vitro].
Zeng WG; Hu P; Wang JN; Liu RB
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):89-93. PubMed ID: 23714660
[TBL] [Abstract][Full Text] [Related]
8. Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
Berardi DE; Flumian C; Campodónico PB; Urtreger AJ; Diaz Bessone MI; Motter AN; Bal de Kier Joffé ED; Farias EF; Todaro LB
Cell Oncol (Dordr); 2015 Aug; 38(4):289-305. PubMed ID: 26044847
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
10. Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells: involvement of protein kinase Calpha and extracellular signal-regulated kinase mitogen-activated protein kinase.
Nakagawa S; Fujii T; Yokoyama G; Kazanietz MG; Yamana H; Shirouzu K
Mol Carcinog; 2003 Nov; 38(3):106-16. PubMed ID: 14587095
[TBL] [Abstract][Full Text] [Related]
11. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
[TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
[TBL] [Abstract][Full Text] [Related]
13. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
16. Aberrant epigenetic regulation of RARβ by TET2 is involved in cutaneous squamous cell carcinoma resistance to retinoic acid.
Zhang X; Cong Y; Chu Z; Shi L; Zheng Y; Zhao Q; Geng S; Guo K
Int J Biochem Cell Biol; 2022 Apr; 145():106190. PubMed ID: 35248720
[TBL] [Abstract][Full Text] [Related]
17. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells.
Eck-Enriquez K; Kiefer TL; Spriggs LL; Hill SM
Breast Cancer Res Treat; 2000 Jun; 61(3):229-39. PubMed ID: 10965999
[TBL] [Abstract][Full Text] [Related]
18. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
[TBL] [Abstract][Full Text] [Related]
20. Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells.
Jinno H; Steiner MG; Nason-Burchenal K; Osborne MP; Telang NT
Int J Oncol; 2002 Jul; 21(1):127-34. PubMed ID: 12063559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
